Women clinical trials

Explore recruiting women clinical trials.

Recruiting women studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Women trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A pivotal, multicentre, randomised, open-label, parallel-group trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 9 cycles in comparison with Desogestrel tablets 0.075 mg.

Hungary, Poland, Spain, Czechia, Germany, Lithuania +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

WOMEN&More: Prospective phase III multi-center open-label study of the efficacy, safety, and acceptability of mifepristone 50 mg once-weekly as a contraceptive

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

The headache- and migraine-inducing effects of apremilast in women with migraine without aura

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A randomized intrapatient cross-over study to assess the efficacy of oxybutynin versus venlafaxine in REDucing hot FLASHes in women using endocrine therapy after breast cancer: the RED FLASH study.

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

C5041053 - A PHASE 1 MULTIPLE-DOSE, OPEN-LABEL PHARMACOKINETIC STUDY OF ETRASIMOD IN HEALTHY LACTATING WOMEN

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

Women trials by city

Women in Toronto Women in Vancouver Women in Montreal Women in Calgary Women in Edmonton Women in Ottawa Women in Winnipeg Women in Quebec City Women in Hamilton Women in Kitchener Women in London Women in Halifax Women in New York Women in Los Angeles Women in Chicago Women in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease